Fully Enabling Genome-Editing System for Crop Improvement Launched
Novel Tool Combines Computational Platform with a Portfolio of CRISPR 3.0 Genome-Editing Nucleases
Bioprocess Control Specialist Focuses on Single-Use Sensors
Lab Automation through Single-Use Sensors and Monitors
Lonza Upgrades Live-Cell Imaging System
For Obtaining Better Cell-Culture Analyses
Antibody Characterization Balances Rigor and Reason
Emphasizes a Combination of Antibody-Dependent and -Independent Testing Methods
For full access to this article login to GEN Select now.
Selecting the Right Drug Candidate
Accurately Predicting In Vivo Hepatotoxicity
- In 2013, the cost of identifying and developing a new drug was on average between $350 million and $5 billion. One major reason for such high development costs is that 95% of the drugs entering clinical trials fail to be both effective and safe. Hepatotoxicity accounts for a ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.